Fibromyalgia — all decisions

The Board denied increased ratings for the Veteran's depressive disorder, fibromyalgia, sciatic radiculopathy of the left lower extremity (LLE), gastroesophageal reflux disease (GERD), and tension headaches. The Board also denied service connection for fatigue.

The appeal for a compensable rating for the chronic rash and claims for service connection for fatigue, muscle pain of the legs, arms, and shoulders, and joint pain of the entire body were denied. The Veteran's appeal pertaining to the issue of entitlement to service connection for neuropsychological symptoms was dismissed.

The appeal for a rating in excess of 10 percent for tinnitus was denied, and the appeals for increased ratings and service connection for various conditions were dismissed as a matter of law due to concurrent elections.

The Board granted service connection for an anxiety disorder and an initial 10 percent rating for irritable bowel syndrome (IBS), but remanded the claims for fibromyalgia, right knee disability, and left knee disability.

The Board denied the veteran's claims for increased ratings and service connection, remanding some issues for further development.

The Board dismissed the appeals for service connection for left bicipital tendonitis and fibromyalgia, but restored a 50 percent rating for bilateral plantar fasciitis with pes planus, heel spurs, and right foot arthritis effective June 1, 2022.

The Board granted service connection for an acquired psychiatric disorder, to include generalized anxiety disorder, and left ear hearing loss. Other claims were denied or remanded.

The Veteran was granted a total disability rating based on individual unemployability (TDIU) due to service-connected fibromyalgia and depression from December 19, 2012, to January 24, 2017, but the claim for TDIU beginning January 24, 2017, was denied.

The Board dismissed the veteran's claims for service connection and earlier effective dates, as well as rating increases, due to procedural defects in the filing of his appeal.

The Board denied a compensable rating for onychomycosis and granted an effective date of September 29, 2010, for fibromyalgia.

The Board denied service connection for chronic fatigue syndrome and fibromyalgia secondary to the Veteran's service-connected bilateral plantar fasciitis, as well as a rating in excess of 30 percent for her bilateral plantar fasciitis.

The Board remands the claims for service connection for bilateral arthritis of the hands, fibromyalgia, and coronary artery disease due to pre-decisional duty to assist errors.

The appeals for service connection for fibromyalgia, narcolepsy, multiple sclerosis, constipation, thoracolumbar myofascial trigger points, GERD, and blurred vision and diplopia were dismissed. The appeal for hypertension was readjudicated based on new evidence.

The Board dismissed the appeals for service connection of chronic fatigue, hypertension, cardiovascular ailments, fibromyalgia, erectile dysfunction, OSA, migraines, lower back pain, and Gulf War Syndrome due to untimely filings or lack of clarification.

The Board remands the issue of an earlier effective date for service connection for fibromyalgia to the Regional Office for further consideration.

The Board denied service connection for cervical dysplasia, tension headaches, and chronic obstructive pulmonary disorder (COPD), and denied increased ratings for right elbow flexion, supination and pronation, extension, and scars. The Board also remanded claims for fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome.

The Board granted an initial 20 percent evaluation for fibromyalgia as the Veteran's symptoms are present more than one-third of the time.

The Board remands the claim for service connection for fibromyalgia due to a lack of sufficient evidence, specifically an examination that was not properly scheduled and notified the Veteran about.

The Board denied the Veteran's claim for service connection for fibromyalgia, finding no current diagnosis of the condition.

The Board denied the Veteran's claims for an earlier effective date for service-connected somatic symptom disorder and fibromyalgia, as there was no evidence of a prior claim that remained pending or that the disabilities first manifested before September 3, 2023.